Literature DB >> 12607062

Is adenocarcinoma of the gastric cardia a distinct entity independent of subcardial carcinoma?

Takashi Ichikura1, Toshiya Ogawa, Toshinobu Kawabata, Kentaro Chochi, Hidekazu Sugasawa, Hidetaka Mochizuki.   

Abstract

Cardia carcinoma has been defined diversely. The purpose of this study was to determine whether cardia carcinoma should be categorized as a distinct entity independent of subcardial carcinoma. We retrospectively analyzed 65 patients undergoing resection for adenocarcinoma involving the esophagogastric junction (EGJ) with the tumor center within 5 cm of the EGJ. Adenocarcinomas of the EGJ were classified into Type I, Type II, and Type III according to Siewert's criteria. There was only one Type I adenocarcinoma, and it was associated with Barrett's esophagus. No tumors had their center between 1 cm and 2 cm proximal to the EGJ. Clinicopathologic features and prognosis were compared among patients with Type II adenocarcinomas ( n = 31), patients with Type III adenocarcinomas ( n = 33), and patients with adenocarcinomas in the upper third of the stomach not invading the EGJ ( n = 153). Siewert's Type II adenocarcinoma was associated with a higher male/female ratio and with higher incidences of well-demarcated appearance and differentiated histology than carcinoma of the upper third of the stomach without esophageal invasion. Lymph nodes along the greater curvature and parapyloric nodes were rarely involved in Type II tumors. Within the pT2 category, patients with Siewert's Type II tumors showed a higher incidence of lymph node metastasis and a significantly lower survival rate than did patients with tumors of the upper third of the stomach without esophageal invasion. In conclusion, cardia carcinoma, appropriately defined as adenocarcinoma with its epicenter between 1 cm proximal and 2 cm distal to the EGJ, should be categorized as a distinct entity.

Entities:  

Mesh:

Year:  2003        PMID: 12607062     DOI: 10.1007/s00268-002-6776-8

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  16 in total

1.  Lymphovascular invasion is associated with poor survival in gastric cancer: an application of gene-expression and tissue array techniques.

Authors:  Bryan J Dicken; Kathryn Graham; Stewart M Hamilton; Sam Andrews; Raymond Lai; Jennifer Listgarten; Gian S Jhangri; L Duncan Saunders; Sambasivarao Damaraju; Carol Cass
Journal:  Ann Surg       Date:  2006-01       Impact factor: 12.969

2.  Effect of lymphadenectomy extent on advanced gastric cancer located in the cardia and fundus.

Authors:  Chang-Ming Huang; Bi-Juan Lin; Hui-Shan Lu; Xiang-Fu Zhang; Ping Li; Jian-Wei Xie
Journal:  World J Gastroenterol       Date:  2008-07-14       Impact factor: 5.742

3.  Expression of ATP7B in human gastric cardiac carcinomas in comparison with distal gastric carcinomas.

Authors:  Da-Long Wu; Hui-Xing Yi; Feng-Ying Sui; Xiao-Hong Jiang; Xiao-Ming Jiang; Ying-Ying Zhao
Journal:  World J Gastroenterol       Date:  2006-12-21       Impact factor: 5.742

4.  Lymph node metastasis in gastric cardiac adenocarcinoma in male patients.

Authors:  Gang Ren; Ying-Wei Chen; Rong Cai; Wen-Jie Zhang; Xiang-Ru Wu; Ye-Ning Jin
Journal:  World J Gastroenterol       Date:  2013-10-07       Impact factor: 5.742

5.  Differential expression of Pim-3, c-Myc, and p-p27 proteins in adenocarcinomas of the gastric cardia and distal stomach.

Authors:  Lei Lou; Yuan Wang; Jinfeng Cui; Xia Yan; Liying Xue; Yuehong Li
Journal:  Tumour Biol       Date:  2014-02-02

Review 6.  Carcinoma of the cardia: classification as esophageal or gastric cancer?

Authors:  Burkhard H A von Rahden; Marcus Feith; Hubert J Stein
Journal:  Int J Colorectal Dis       Date:  2004-10-26       Impact factor: 2.571

Review 7.  Surgical management of esophagogastric junction tumors.

Authors:  Burkhard H A von Rahden; Hubert J Stein; J Rüdiger Siewert
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

8.  Is adenocarcinoma of the esophagogastric junction different between Japan and western countries? The incidence and clinicopathological features at a Japanese high-volume cancer center.

Authors:  Shinichi Hasegawa; Takaki Yoshikawa; Haruhiko Cho; Akira Tsuburaya; Osamu Kobayashi
Journal:  World J Surg       Date:  2009-01       Impact factor: 3.352

9.  Clinicopathologic comparison of Siewert type II and III adenocarcinomas of the gastroesophageal junction.

Authors:  Norihiro Yuasa; Hideo Miyake; Tatsuharu Yamada; Tomoki Ebata; Yuji Nimura; Tatsuo Hattori
Journal:  World J Surg       Date:  2006-03       Impact factor: 3.352

Review 10.  The role of laparoscopy for gastric surgery in the West.

Authors:  Vivian E Strong; Nicolas Devaud; Martin Karpeh
Journal:  Gastric Cancer       Date:  2009-11-05       Impact factor: 7.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.